First Horizon Corporation’s Regeneron Pharmaceuticals REGN Stock Holding History

First Horizon Corporation’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$383K	Sell	615 -168	-21%	-$114K	0.01%	332
2026 Q1	$605K	Sell	783 -389	-33%	-$298K	0.03%	264
2025 Q4	$905K	Sell	1,172 -9,911	-89%	-$6.73M	0.04%	222
2025 Q3	$6.23M	Buy	+11,083	New	+$6.27M	0.29%	102
2021 Q2	$220K	Buy	395 +50	+14%	+$25.3K	0.02%	220
2021 Q1	$163K	Sell	345 -173	-33%	-$84.2K	0.02%	251
2020 Q4	$250K	Buy	518 +40	+8%	+$21.6K	0.02%	204
2020 Q3	$267K	Buy	+478	New	+$290K	0.03%	192

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

First Horizon Corporation's REGN Position: Q2 2026 in Review

First Horizon Corporation reduced its Regeneron Pharmaceuticals (REGN) stake by 21% in Q2 2026, selling an estimated $114K and leaving 615 shares worth $383K. The position accounts for 0.01% of the portfolio, ranked #332.

First Horizon Corporation first reported a position in REGN in Q3 2020 and has held it in 8 quarters since. The position peaked at $6.23M in Q3 2025. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

First Horizon Corporation held 615 shares of Regeneron Pharmaceuticals worth $383K as of Q2 2026.
First Horizon Corporation sold 168 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $114K.
Regeneron Pharmaceuticals made up 0.01% of First Horizon Corporation's portfolio in Q2 2026, its #332 holding.
First Horizon Corporation first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 8 quarters since.
First Horizon Corporation's Regeneron Pharmaceuticals position peaked at $6.23M in Q3 2025.
518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.